Wide Benefit, Less Toxic
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin Oriental Hotel Jakarta, which was conducted in Hybrid mode and participated by 31 HCPs offline and 7 HCPs online. In the 1st scientific session moderated by Dr. dr. Andri Sanityoso, […]
Overview PPHI Website
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali situs resminya di tahun 2022 ini dengan alamat pbpphi.org. Lihat fitur apa saja yang ada dalam situs PPHI dengan menyimak video berikut: Berikut adalah cara untuk mendaftarkan diri di website […]
Enhancing Interprofessional Collaboration for Improving Hepatobiliary Diseases Management
2 mn read“Virtual The 14th Liver Update and The Annual Scientific Meeting of Ina ASL/PPHI 2022” symposium is organized by Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital and Indonesian Association for the Study of the Liver (Ina ASL/PPHI).
Virtual Liver Update 2022 – Clinical Associate Prof Tai Wai Meng David, Singapore Session
< 1 mn readClinical Associate Prof Tai Wai Meng David was giving his presentation on Implications of Immunotherapy Data in Unresectable HCC. There were three highlights from his session:
Wide Benefit, Less Toxic
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin Oriental Hotel Jakarta, which was conducted in Hybrid mode and participated by 31 HCPs offline and 7 HCPs online. In the 1st scientific session moderated by Dr. dr. Andri Sanityoso, […]
Overview PPHI Website
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali situs resminya di tahun 2022 ini dengan alamat pbpphi.org. Lihat fitur apa saja yang ada dalam situs PPHI dengan menyimak video berikut: Berikut adalah cara untuk mendaftarkan diri di website […]
Wide Benefit, Less Toxic
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin Oriental Hotel Jakarta, which was conducted in Hybrid mode and participated by 31 HCPs offline and 7 HCPs online. In the 1st scientific session moderated by Dr. dr. Andri Sanityoso, […]
Overview PPHI Website
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali situs resminya di tahun 2022 ini dengan alamat pbpphi.org. Lihat fitur apa saja yang ada dalam situs PPHI dengan menyimak video berikut: Berikut adalah cara untuk mendaftarkan diri di website […]
Enhancing Interprofessional Collaboration for Improving Hepatobiliary Diseases Management
2 mn read“Virtual The 14th Liver Update and The Annual Scientific Meeting of Ina ASL/PPHI 2022” symposium is organized by Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital and Indonesian Association for the Study of the Liver (Ina ASL/PPHI).
Virtual Liver Update 2022 – Clinical Associate Prof Tai Wai Meng David, Singapore Session
< 1 mn readClinical Associate Prof Tai Wai Meng David was giving his presentation on Implications of Immunotherapy Data in Unresectable HCC. There were three highlights from his session:
Indonesian consensus on systemic therapies for hepato cellular carcinoma
< 1 mn readAbstract Hepatocellular carcinoma (HCC) is a deadly cancer with a rising incidence in the last 20 years. Most patients are diagnosed late when curative treatment is no longer feasible. With the background of chronic liver disease in most patients, the management of HCC becomes more complicated, in which well-preserved liver function is a prerequisite for […]
